Androgen deprivation therapy as adjuvant/neoadjuvant to radiotherapy for high-risk localised and locally advanced prostate cancer: recent developments-Reference-Cited by-同舟云学术

Androgen deprivation therapy as adjuvant/neoadjuvant to radiotherapy for high-risk localised and locally advanced prostate cancer: recent developments

Published:2011-10-18 Issue:11 Volume:105 Page:1628-1634
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Payne H,Mason M

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/bjc2011385.pdf

Reference42 articles.

1. Alexander A, Crook J, Jones S, Malone S, Bowen J, Truong P, Pai H, Ludgaate C (2010) Is biochemical response more important than duration of neoadjuvant hormone therapy before radiotherapy for clinically localized prostate cancer? An analysis of the 3- vs 8-month randomized trial. Int J Radiat Oncol Biol Phys 76: 23–30

2. Aral IA, Hussain F, Godec C (2010) Prostate cancer – external beam radiotherapy. 2010. Available at: http://emedicine.medscape.com/article/454283-overview . Last accessed: July 2011

3. Boccon-Gibod L, van der Meulen E, Persson B-E (2011) An update on the use of gonadotropin-releasing hormone antagonists in prostate cancer. Ther Adv Urol 3: 127–140

4. Bolla M, Collette L, Blank L, Warde P, Dubois JB, Mirimanoff RO, Storme G, Bernier J, Kuten A, Sternberg C, Mattelaer J, Lopez Torecilla J, Pfeffer JR, Lino Cutajar C, Zurlo A, Pierart M (2002) Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial. Lancet 360: 103–108

5. Bolla M, Collette L, van Tienhoven G, Warde P, Dubois JB, Mirimanoff RO, Storme GA, Bernier J, Kuten A, Piérart M (2009a) Three years of adjuvant androgen deprivation with goserelin in patients with locally advanced prostate cancer treated with radiotherapy: results at 10 years of EORTC trial 22863. Eur J Cancer Suppl 45 (suppl1): 408

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Balancing Hormone Therapy: Mitigating Adverse Effects of Androgen-Deprivation Therapy and Exploring Alternatives in Prostate Cancer Management;American Society of Clinical Oncology Educational Book;2024-06

2. Agent-based modeling of the prostate tumor microenvironment uncovers spatial tumor growth constraints and immunomodulatory properties;npj Systems Biology and Applications;2024-02-21

3. Agent-based modeling of the prostate tumor microenvironment uncovers spatial tumor growth constraints and immunomodulatory properties;2023-07-27

4. Remodeling Tumor Immune Microenvironment by Using Polymer-Lipid-Manganese Dioxide Nanoparticles with Radiation Therapy to Boost Immune Response of Castration-Resistant Prostate Cancer;Research;2023-01

5. Gene expression analysis reveals a 5-gene signature for progression-free survival in prostate cancer;Frontiers in Oncology;2022-08-12